Is AbbVie Inc (ABBV) a Stock to Watch After Losing -7.10% This Week?

Overall market sentiment has been down on AbbVie Inc (ABBV) stock lately. ABBV receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

AbbVie Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on ABBV!

See Full ABBV Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With ABBV Stock Today?

AbbVie Inc (ABBV) stock is lower by -7.15% while the S&P 500 is higher by 0.76% as of 10:15 AM on Thursday, Apr 27. ABBV has fallen -$11.57 from the previous closing price of $161.82 on volume of 3,688,865 shares. Over the past year the S&P 500 is down -2.12% while ABBV has fallen -3.80%. ABBV earned $6.63 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 22.68.

More About AbbVie Inc

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health. Click Here to get the full Stock Report for AbbVie Inc stock.